ப்ரைமரீ ப்ரோக்ரெஸிவ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரைமரீ ப்ரோக்ரெஸிவ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரைமரீ ப்ரோக்ரெஸிவ் Today - Breaking & Trending Today

Mr. Mitch: Lazy


Open share drawer
The London producer and label boss’ third album responds to a year of uncertainty with a mixture of club-friendly styles and melancholic touches for the lonely wee hours.
Featured Tracks:
“Lazy” [ft. Manga Saint Hilare] — Mr. MitchVia 
When he’s not writing music as Mr. Mitch, Miles Mitchell runs a record label (Gobstopper), raises his growing family in southeast London (they welcomed a daughter last April), and holds down a full-time job. When venues are open, he’s one-quarter of the team behind Boxed, one of the most quietly influential club nights that London has produced in the past decade. In 2020, he released two new EPs, including a collaboration with his two young sons (proceeds went towards their video gaming gear), as well as two Bandcamp collections of older, mostly unheard material. All the while, he continued work on ....

City Of , United Kingdom , Miles Mitchell , They Want , Saint Hilare , Primary Progressive , Mr Mitch , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , மைல்கள் மிட்செல் , அவர்கள் வேண்டும் , ப்ரைமரீ ப்ரோக்ரெஸிவ் , திரு மிட்ச் ,

Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER


Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER
Specialty Care sales grew 18.3%, driven by strong Dupixent
performance (+54.2% to €982 million).
Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH.
General Medicines declined 7.5%, reflecting lower U.S. Diabetes sales, COVID environment and portfolio streamlining.
CHC down 3.0% due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands.
Leveraged business EPS as the result of prioritization within R&D and continued execution on smart spending initiatives.
Sales down 2.4% and business EPS flat on a reported basis, as a result of the overall adverse impact from foreign currency rates. ....

United States , United Kingdom , Renagel Renvela , Paul Hudson , Sanofi Regeneron , Synvisc Synvysc , Digestive Health , European Association Of Haemophilia , Sanofi Espoir Foundation , International Society On Thrombosis , Oncology Alliance , Us District Court , Sanofi Business Services , European Union , Animal Health Items , European Commission , Drug Administration , Antibodies Alliance , National Institute For Health , National Reimbursement Drug List , Sanofi Animal Health , Animal Health , European Society For Medical Oncology , Chief Executive Officer , General Medicines , Consumer Healthcare ,